(4/13, Smith) reports, "Metformin, the gold standard for treating type
2 diabetes, may not be so golden after all," according to a meta-analysis
published in the PLoS Medicine. After examining some 25 studies
encompassing "9,560 patients given metformin and 3,550 given
conventional treatment or placebo," researchers found that metformin
"had no effect on all-cause or cardiovascular mortality in people with
diabetes."
No comments:
Post a Comment